發布於 · 2024年8月1日 · 語音AI · 認知退化 · Alzheimer's · 數位生物標誌物
遠端數位語音聲學評估於認知正常成人之可行性、可靠性與類澱粉蛋白病理之關聯
多日遠端語音評估具高可行性與可靠性，且對類澱粉蛋白相關變化具潛在敏感性，支持其作為早期 Alzheimer's 病數位生物標誌物的開發。
Remote multi-day speech assessment is feasible, reliable, and potentially sensitive to amyloid-beta-related changes in cognitively unimpaired older adults, supporting its development as a digital biomarker for early Alzheimer’s disease.